Medical Journals

Sildenafil Citrate Attenuates a Complex Maze Impairment Induced by Intracerebroventricular Infusion of the Nos Inhibitor Nomega-nitro-l-arginine Methyl Ester.

Authors:
  • Devan Bryan D
  • Pistell Paul J
  • Daffin Lee W
  • Nelson Christopher M
  • Duffy Kara B
  • Bowker Jonna L
  • Bharati Ila S
  • Sierra-Mercado Demetrio
  • Spangler Edward L
  • Ingram Donald K

From: Behavioral Neuroscience Section, Laboratory of Experimental Gerontology, National Institute on Aging, National Institutes of Health, Gerontology Research Center, 5600 Nathan Shock Dr., Baltimore MD 21204, United States. bdevan@towson.edu

European journal of pharmacology

  • Publish Date: Jun 2007
  • ISSN: 0014-2999
  • Volume: 563
  • Issue: 1-3
  • Pages: 134-40
  • Medium: Print
  • Language: English
  • Citation (JAMA): Devan Bryan D, Pistell Paul J, Daffin Lee W, et al. Sildenafil Citrate Attenuates a Complex Maze Impairment Induced by Intracerebroventricular Infusion of the Nos Inhibitor Nomega-nitro-l-arginine Methyl Ester.. Eur. J. Pharmacol. Jun 2007;563:134-40

Abstract

In a previous study, our laboratory reported that sildenafil citrate, a cyclic nucleotide phosphodiesterase type 5 inhibitor, reversed a learning impairment in rats induced by systemic inhibition of nitric oxide synthase (60 mg/kg, i.p., Nomega-nitro-L-arginine methyl ester; L-NAME). To limit the peripheral effects of L-NAME and further localize the site of action of sildenafil, L-NAME (48 microg, i.c.v.) was infused bilaterally into the lateral cerebral ventricles 30 min prior to maze training. Saline or sildenafil citrate (1.5 or 3.0 mg/kg, i.p.) was administered systemically 15 min before training. Drug injections occurred 24 h after pretraining rats to avoid foot shock on a one-way active avoidance straight runway. Following drug treatment, the rats received 15 training trials on a 14-unit T-maze task that requires learning a complex sequence of turns to avoid mild foot shock. This complex maze paradigm is sensitive to aging and blockade of cholinergic, N-methyl-D-aspartate and nitric oxide signaling systems. Behavioral measures of performance included deviations from the correct pathway (errors), runtime from start to goal (latency), shock frequency and shock duration. Statistical analysis revealed that central infusion of L-NAME impaired maze performance and that sildenafil (3.0 mg/kg) significantly attenuated the impairment. These results suggest that sildenafil citrate may serve as a cognitive enhancer by modulating central nitric oxide/cGMP signal transduction following N-methyl-D-aspartate receptor activation. This pathway has been implicated in age-related cognitive decline and may be a useful target for pharmacological intervention of neurodegenerative disease.

Mesh Headings (Keywords): 3’,5’-Cyclic-GMP Phosphodiesterases, Animals, Behavior, Animal, Brain, Cognition, Cyclic GMP, Cyclic Nucleotide Phosphodiesterases, Type 5, Dose-Response Relationship, Drug, Enzyme Inhibitors, Infusions, Parenteral, Injections, Intraperitoneal, Male, Maze Learning, NG-Nitroarginine Methyl Ester, Nitric Oxide, Nitric Oxide Synthase, Nootropic Agents, Phosphodiesterase Inhibitors, Piperazines, Purines, Rats, Rats, Inbred F344, Signal Transduction, Sulfones


Check for Full Text / PubMed Unique Identifier (PMID): 17362916


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.